# Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors

> **NCT00605566** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 22 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DRUG:** Sorafenib
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00605566
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605566, "Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00605566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*